NIAID Seeks Partners for CRADA on Dengue Virus Vaccine Development

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking partners to collaborate on a Cooperative Research and Development Agreement (CRADA) to develop live attenuated dengue viruses as vaccines to prevent dengue hemorrhagic fever and dengue shock syndrome in humans.